3431 - 3440 of 8137 Results
Title
Year
-
OPENTitle: Thalamic morphology predicts the onset of freezing of gait in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00163-0Best OA location URL: https://www.nature.com/articles/s41531-021-00163-0.pdfCitation Count: 24
-
RESTRICTEDTitle: Adapting the proteostasis capacity to sustain brain healthspanJournal Name: CellPublisher: Elsevier BVVol: 184Issue #: 6Start Page: 1545End Page: 1560Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.cell.2021.02.007Best OA location URL: http://www.cell.com/article/S0092867421001574/pdfCitation Count: 66
- Closed-Loop Deep Brain Stimulation to Treat Medication-Refractory Freezing of Gait in Parkinson’s Disease2021OPENTitle: Closed-Loop Deep Brain Stimulation to Treat Medication-Refractory Freezing of Gait in Parkinson’s DiseaseJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2021.633655Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnhum.2021.633655/pdfCitation Count: 34
- Investigating the relationship between the SNCA gene and cognitive abilities in idiopathic Parkinson’s disease using machine learning2021OPENTitle: Investigating the relationship between the SNCA gene and cognitive abilities in idiopathic Parkinson’s disease using machine learningJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-84316-4Best OA location URL: https://www.nature.com/articles/s41598-021-84316-4.pdfCitation Count: 20
- Management of Secondary Poor Response to Botulinum Toxin in Cervical Dystonia: A Multicenter Audit2021OPENTitle: Management of Secondary Poor Response to Botulinum Toxin in Cervical Dystonia: A Multicenter AuditJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 4Start Page: 541End Page: 545Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13181Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13181Citation Count: 5
-
OPENTitle: Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s diseaseJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2086Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/brb3.2086Citation Count: 6
-
OPENTitle: Reply to: “Cell Therapy for Huntington's Disease: Learning from Failure”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 3Start Page: 788End Page: 789Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28500Best OA location URL: http://deepblue.lib.umich.edu/bitstream/2027.42/167074/1/mds28500_am.pdfCitation Count: 1
-
RESTRICTEDTitle: Targeting β-Arrestins in the Treatment of Psychiatric and Neurological DisordersJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 35Issue #: 3Start Page: 253End Page: 264Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40263-021-00796-yCitation Count: 8
-
RESTRICTEDTitle: The role of immune-mediated alterations and disorders in ALS diseaseJournal Name: Human ImmunologyPublisher: Elsevier BVVol: 82Issue #: 3Start Page: 155End Page: 161Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.humimm.2021.01.017Best OA location URL: https://doi.org/10.1016/j.humimm.2021.01.017Citation Count: 19
- The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism2021OPENTitle: The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonismJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00162-1Best OA location URL: https://www.nature.com/articles/s41531-021-00162-1.pdfCitation Count: 15